GastroenterologyRheumatology

INFLECTRA

INFLECTRA (infliximab-dyyb) is a monocloncal antibody used to treat a range of inflammatory autoimmune diseases.
Infusion or injection therapy referral
What it treats Rheumatoid Arthritis,
Crohn’s Disease,
Arthritis of the spine,
Psoriatic Arthritis,
Ulcerative Colitis,
Plaque Psoriasis,
Ankylosing Spondylitis
Prescribed by Rheumatologists & Gastroenterologists
How it’s administered Intravenous (IV) infusion
Frequency Zero, two & six weeks, followed by a maintenance regimen every eight weeks
Length of treatment Two hours

About This Therapy

INFLECTRA (infliximab-dyyb) is a monocloncal antibody used to treat a range of inflammatory autoimmune diseases. 

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

INFLECTRA REFERRAL FORM

INFLECTRA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for INFLECTRA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.